2015 Pharmaceutical Innovation and Development Summit Forum held in Shanghai in May
-
Last Update: 2020-05-13
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Breakthrough And Win-Win Cooperation - The 2015 China (Shanghai) Pharmaceutical Innovation and Development Summit Will Be Held on May 15, 2015 at the National Convention and Exhibition Center in Shanghai, China.
In 2015, under the background of comprehensive deepening of health care reform, the medical industry will face more vigorous policy changes Price reform, health care reform, bidding process and other policies will have a more far-reaching impact on the pharmaceutical industry At the same time, in the new policy tightening environment, pharmaceutical companies will have more change behavior, and the right choice will bring more diversified investment choices how to correctly interpret the new medicine policy, rationally judge the trend of change, choose a reasonable investment mode is the direction of general concern of the pharmaceutical industry To this end, the country's largest medical technology information service platform - "Pharma Intelligence Network" will be joint news portal, industry media in May 15, 2015 in Shanghai, China, the National Convention and Exhibition Center to host the "breakthrough re-encirclement cooperation and win-win" - 2015 China (Shanghai) Pharmaceutical Innovation and Development Summit Forum.
It is reported that this forum to "break through the re-encirclement, win-win cooperation" as the theme, focusing on the 2015 medical industry's latest policy and regulations, explore innovative new models of the pharmaceutical industry, promote cooperation in resources for in-depth discussion and prospects Topics of this forum include: dynamic analysis of pharmaceutical laws and regulations in 2015, real combat of pharmaceutical marketing in 2015, real-world analysis of new drug research and development - information acquisition and utilization, interpretation of drug technology transfer policy and project docking, development and challenges of pharmaceutical enterprises in 2015.
Participants include domestic pharmaceutical industry first-class authoritative experts, senior scholars, industry authorities, pharmaceutical manufacturers, heads of scientific research units, pharmaceutical sales companies, news portals and "pharmaceutical observer", "pharmaceutical economic newspaper" industry media will provide media support throughout the process.
At that time, China Pharmaceutical Enterprise Management Association President Yu Mingde, Medical Observer Newspaper Editor-in-Chief Ho Ju, "Control Marketing" founder Cheng Jizhong and well-known pharmaceutical intelligence expert professor Hou Wei and other domestic pharmaceutical industry authoritative experts and industry authorities, pharmaceutical production listed company president, pharmaceutical circulation listed company president will be on the same stage, for this summit forum to give a keynote speech, to explore the future of the pharmaceutical industry and the future.
We look forward to more medical colleagues, in the process of exchanges and discussions to break through the re-encirclement, win-win cooperation Let us meet in Shanghai National Convention and Exhibition Center, we look forward to a better tomorrow!
About the organizers: Pharmaceutical Intelligence Network () is the largest pharmaceutical information technology service platform, with a huge pharmaceutical industry membership resources, is China's largest pharmaceutical technology information service platform, committed to promoting the development of the pharmaceutical industry and technological progress Its own pharmaceutical intelligence platform, pharmaceutical intelligence data, pharmaceutical IQ city, pharmaceutical intelligence news, pharmaceutical intelligence forum and other sectors, is for the pharmaceutical industry chain to provide a full range of technology and information services dedicated platform.
Summit Registration Hotline: 400-678-0778
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.